[Consensus on HPV of the Portuguese Society of Andrology, Sexual Medicine and Reproduction: Treatment].

Revista Internacional De Andrología
Bruno Jorge PereiraPedro Vendeira

Abstract

The treatment of condyloma is generally a challenge in clinical practice. Although the spontaneous resolution rate is high, a significant proportion of patients seek treatment, not because of symptomatology, but mainly for aesthetic issues and concerns related to the transmission or worsening of existing lesions. The available treatments should be applied only for clinically evident macroscopic lesions. Ideally, available therapies should have rapid action onset and clearance, resolve symptoms, reduce recurrence rate and viral load, be effective in treating small lesions, and be well tolerated. However, none of the currently available treatments is clearly more effective than the others and there is no ideal treatment for all patients or for all condyloma. Therefore, the therapeutic decision should be based on the clinician's experience, available resources, lesion morphology, size, number and location, primary or recurrent lesions, disease severity, patient preference and expectations, patient's immune competence, convenience, tolerance, cost of treatment and results of previous therapies. The available treatments are divided into three groups: applied by the patient himself (imiquimod 3.75 or 5%, podophyllotoxin .5%, synecate...Continue Reading

References

Jan 1, 1990·Scandinavian Journal of Urology and Nephrology·P H GraversenP Rosenkilde
Apr 15, 1989·Lancet·K R BeutnerD H King
Jan 25, 1986·Lancet·H T Khawaja
Dec 1, 1987·Genitourinary Medicine·M J GodleyR N Thin
Aug 1, 1996·International Journal of STD & AIDS·M ReynoldsC J Lacey
Oct 1, 1996·International Journal of STD & AIDS·U ClaessonA Siboulet
Feb 5, 1998·Archives of Dermatology·S TyringT Toter
Apr 29, 1998·Antimicrobial Agents and Chemotherapy·K R BeutnerK A Schmitt
Feb 13, 2001·The British Journal of Dermatology·J C SterlingUNKNOWN British Association of Dermatologists
Jul 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R SnoeckE De Clercq
Mar 5, 2002·Sexually Transmitted Diseases·Giuseppe De PanfilisSevero Graifemberghi
Aug 7, 2003·Sexually Transmitted Infections·C J N LaceyUNKNOWN Perstop Pharma Genital Warts Clinical Trial Group
Oct 21, 2003·International Journal of Cancer. Journal International Du Cancer·Maaike C G BleekerChris J L M Meijer
Oct 21, 2003·International Journal of Cancer. Journal International Du Cancer·Cornelis J A HogewoningChris J L M Meijer
Feb 11, 2004·International Journal of STD & AIDS·M CusiniE Alessi
Jul 5, 2007·International Journal of STD & AIDS·Jackie Sherrard, Lynn Riddell
Mar 28, 2008·The British Journal of Dermatology·E StockflethC Thielert
Jun 25, 2008·International Journal of STD & AIDS·Christina StefanakiAndreas Katsambas
May 15, 2009·Indian Journal of Dermatology, Venereology and Leprology·S B DharMsi Bhuiyan
Jun 23, 2009·Sexually Transmitted Diseases·Aris D'AmbrogioJean-Claude Givel
Aug 28, 2009·The British Journal of Dermatology·S TattiA Mescheder
Sep 24, 2009·BMC Infectious Diseases·Jin YangQi-Wen Deng
Oct 13, 2010·Sexually Transmitted Diseases·Peter KomerickiWerner Aberer
May 25, 2011·Sexually Transmitted Infections·Bhushan Kumar, Tarun Narang
Feb 2, 2012·American Journal of Clinical Dermatology·Federica Dall'oglioGiuseppe Micali
Mar 14, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·C J N LaceyJ Ross
Nov 28, 2012·Enfermedades infecciosas y microbiología clínica·Teresa Fernández-MoranoMagdalena de Troya-Martín
Apr 29, 2014·Expert Opinion on Biological Therapy·Eggert Stockfleth, Thomas Meyer
Apr 29, 2014·Anais Brasileiros De Dermatologia·Caio Lamunier de Abreu CamargoRicardo Romiti
Sep 23, 2014·Der Urologe. Ausg. A·W BrummeislS Denzinger
Feb 26, 2015·International Journal of STD & AIDS·Álvaro VivesMarco Cosentino
Nov 26, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ina U ParkEileen F Dunne
Jan 13, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T CaiR Bartoletti
Oct 12, 2016·Annales de dermatologie et de vénéréologie·O Cogrel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Sexually Transmitted Diseases
Shunya SugaiTakayuki Enomoto
Actas urologicas españolas
V Gonzalvo PérezJ Zaragoza Orts
Diseases of the Colon and Rectum
Richard J SilveraStephen E Goldstone
© 2021 Meta ULC. All rights reserved